New Position for Price Controls on Pharma Within USTR Proposed
Rep. Vern Buchanan, R-Fla., and Rep. Jodey Arrington, R-Texas, reintroduced a bill that would add a position at the Office of the U.S. Trade Representative for identifying and reporting annually on foreign price-setting for pharmaceuticals, and to recommend trade remedies. The USTRx Act would call his position the chief pharmaceutical trade negotiator.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
“American patients are paying more for life-saving medicines because foreign countries are free-riding on U.S. investment and innovation,” Buchanan said in an Aug. 4 press release. “This is not only unfair, it’s unsustainable.”